# Boule Diagnostics Q3 Earnings Drop

> Boule Diagnostics AB reported a 24.4% sales decline in Q3 2026 due to component shortages and weak demand.
- Title: Boule Diagnostics Q3 Earnings Drop · Seekingalpha | Shortify
- Summary: Boule Diagnostics AB reported a 24.4% sales decline in Q3 2026 due to component shortages and weak demand. Boule Diagnostics AB's Q3 2026 sales dropped 24.4%…
- Keywords: boule diagnostics, q3 2026, sales decline, component shortages, weak demand, instrument sales, money, business, Boule, Diagnostics, Earnings, Drop
- Source: Seekingalpha — https://seekingalpha.com/article/4956956-boule-diagnostics-ab-publ-bdabf-q3-2026-earnings-call-prepared-remarks-transcript
- Author: SA Transcripts
- Published: 2026-10-23T14:07:22+00:00
- Read time: 1 min
- Topics: boule diagnostics, q3 2026, sales decline, component shortages, weak demand, instrument sales, money, business
## Q3 2026 Earnings Call
Boule Diagnostics AB held its Q3 2026 earnings call on October 23, 2026.
## Sales Decline
Net sales decreased by 24.4% with organic decline of 19.4% and currency effects of 5%.
## Component Shortages
Component shortages limited instrument deliveries, affecting 3-part human and 4-part veterinary instruments.
## Key takeaway

Boule Diagnostics AB's Q3 2026 sales dropped 24.4% from component shortages and weak demand.